Skip Navigation

‘HIV-ending’ drug could be made for just $25 per patient a year, say researchers

www.theguardian.com ‘HIV-ending’ drug could be made for just $25 per patient a year, say researchers

As regulator prepares to approve Lenacapavir in the US, campaigners are urging the manufacturer, Gilead, to make it ‘available and affordable for all who need it’

‘HIV-ending’ drug could be made for just $25 per patient a year, say researchers
48

You're viewing a single thread.